Structure-based tailoring of the first coumarins-specific bergaptol O-methyltransferase to synthesize bergapten for depigmentation disorder treatment.

•The PpBMT crystal structure identified key amino acids in bergaptol conversion.•Protein engineering was used to obtain PpBMT mutants with improved activity.•A high-activity mutant was used to produce bergapten for pharmacological analysis.